Table 1 Association of CST6 methylation status with clinicopathological features for the independent group (n = 80)
Clinicopathological features | CST6 methylation | ||||
|---|---|---|---|---|---|
| Â | Â | n | + (%) | - (%) | P value* |
Age (years) | <55 | 42 | 22 (52.4) | 20 (47.6) | 0.495 |
|  | ≥55 | 38 | 17 (44.7) | 21 (55.3) |  |
Menopausal status | Pre | 34 | 18 (52.9) | 16 (47.1) | 0.519 |
| Â | Post | 46 | 21 (45.7) | 25 (54.3) | Â |
Tumor size (cm) | 0-2.0 | 23 | 11 (47.8) | 12 (52.2) | 0.682 |
| Â | 2.1-5.0 | 48 | 22 (45.8) | 26 (54.2) | Â |
| Â | >5.0 | 8 | 5 (62.5) | 3 (37.5) | Â |
Axillary lymph node | 0 | 23 | 9 (39.1) | 14 (60.9) | 0.366 |
| Â | 1-3 | 28 | 14 (50.0) | 14 (50.0) | Â |
|  | ≥4 | 27 | 16 (59.3) | 11 (40.7) |  |
Tumor grade | Ι | 22 | 8 (36.4) | 14 (63.6) | 0.172 |
|  | ΙΙ, ΙΙΙ | 58 | 31 (53.4) | 27 (46.6) |  |
Estrogen receptor | Positive | 49 | 22 (44.9) | 27 (55.1) | 0.386 |
| Â | Negative | 31 | 17 (54.8) | 14 (45.2) | Â |
Progesterone receptor | Positive | 26 | 10 (38.5) | 16 (61.5) | 0.201 |
| Â | Negative | 54 | 29 (53.7) | 25 (46.3) | Â |